In 2036, you will be glad you bought these ASX shares today

Want to make long term investments? I think these shares could be top picks.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • Lovisa's global expansion and scalable fast-fashion jewellery concept offer potential long-term growth, fuelled by its ability to replicate success across various markets with strong returns.
  • Telix Pharmaceuticals is transitioning from a speculative biotech to a revenue-generating force in radiopharmaceuticals, poised to capitalise on growing demand for cancer diagnostics, despite recent regulatory challenges.
  • Temple & Webster's online-only model and digital disruption strategy could secure long-term gains as it capitalises on the shift towards e-commerce in the traditionally offline furniture market.

I'm a big fan of buy and hold investing and believe it is one of the best ways to grow wealth.

But which ASX shares could be worth buying and holding for the long term? Let's take a look at three that I think could be wealth generators over the next decade. They are as follows:

A man points at a paper as he holds an alarm clock, indicating the ex-dividend date is approaching.

Image source: Getty Images

Lovisa Holdings Ltd (ASX: LOV)

Lovisa is a great example of how powerful a simple concept can become when executed well. What began as a fast-fashion jewellery retailer in Australia has evolved into a global roll-out machine, with over a thousand stores now operating across the world.

The real attraction here is its scalability. Lovisa's store economics have proven repeatable across geographies, allowing it to expand aggressively while still generating strong returns on capital. Unlike many retailers, it carries limited fashion risk due to its low price point and fast inventory turnover, which keeps customers coming back regularly.

If Lovisa can continue executing its international expansion strategy over the next decade, today's footprint could look very small in hindsight.

Telix Pharmaceuticals Ltd (ASX: TLX)

Another ASX share that could be a top option for buy and hold investors is Telix Pharmaceuticals.

It offers exposure to a completely different growth driver. That is the global healthcare and diagnostics market. Telix specialises in radiopharmaceuticals, which are used to detect and treat cancer with far greater precision than traditional methods.

What makes Telix attractive is that it has already crossed an important threshold. It has moved beyond being a purely speculative biotech and into a commercial phase, with approved products generating growing revenue, while a broader pipeline continues to advance.

Unfortunately, it has not been plain sailing this year, with the US FDA knocking back applications. However, management appears confident it will be able to gain approval next year after responding to the regulator's concerns.

In light of this, with demand for cancer diagnostics and targeted therapies is only expected to grow, now could be an opportune time to buy Telix shares while they are trading down near their 52-week low.

Temple & Webster Group Ltd (ASX: TPW)

Finally, Temple & Webster is a classic long-term digital disruption story. It operates in a category that has been slow to move online, giving it a significant opportunity to keep taking market share as consumer behaviour evolves.

Unlike traditional furniture retailers, Temple & Webster benefits from a capital-light, online-only model. This gives it flexibility and operating leverage as volumes grow.

And with online penetration in the Australian furniture market still much lower than in other Western markets, the next 10 years could be very fruitful for Temple & Webster and materially change the scale of the business.

Motley Fool contributor James Mickleboro has positions in Lovisa and Temple & Webster Group. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Lovisa, Telix Pharmaceuticals, and Temple & Webster Group. The Motley Fool Australia has recommended Lovisa, Telix Pharmaceuticals, and Temple & Webster Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

flying asx share price represented by man flying remote control drone
Growth Shares

Why are DroneShield shares suddenly rising again?

A guidance miss, then a sharp bounce. What changed?

Read more »

Person handing out $50 notes, symbolising ex-dividend date.
Growth Shares

Where I'd invest $25,000 into ASX shares in August

I outline why these shares could be top picks for investors this month and for years to come.

Read more »

A female soldier flies a drone using hand-held controls.
Growth Shares

ASX defence shares have been the trade of the decade. Is it too late to join the party?

Order books are growing. Share prices aren't.

Read more »

Group of people cheer around tablets in office
Growth Shares

3 growing ASX 300 shares I'd buy with $5,000

All three businesses have something to prove, but strong execution could make them considerably larger over time.

Read more »

Excited couple celebrating success while looking at smartphone.
Growth Shares

5 ASX shares I'd buy with $5,000 in August

I think these ASX 200 shares are now trading below fair value.

Read more »

A boy stands in front of two similar but slightly different doors, scratching his head as to which one to choose.
Growth Shares

Looking for both growth and income? This ASX share is the perfect choice

You don't always have to choose between growth and income.

Read more »

Three business people stand on platforms in the desert and look out through telescopes.
Growth Shares

2 top ASX shares to buy and hold for the next decade

These ASX shares have a lot to offer long-term investors.

Read more »

Woman using a pen on a digital stock market chart in an office.
Growth Shares

My top ASX 200 stock picks for August

I think the next decade could give these market leaders plenty of time to deepen their advantages.

Read more »